Key result
Lipoprotein(a) levels were elevated in patients with coronary heart disease carrying other important risk factors.
Observational
Answers are grounded in this paper and cite their sources.
Lipoprotein(a) [Lp(a)] comprises of an LDL particle and apolipoprotein(a) [apo(a)] and its elevated levels are considered a risk factor for atherosclerosis. The aim of our study was to find out whether elevated Lp(a) levels are associated with increased risk of atherosclerosis in patients with multiple other risk factors. We further tested the association of three polymorphisms of the apo(a) gene promoter with Lp(a) levels. No significant correlation was detected between Lp(a) levels and lipid and clinical parameters tested. The study demonstrated a significantly (p=0.0219) elevated Lp(a) level (mean 28+/-35 mg/dl, median 0.14) in patients with coronary heart disease (CHD). In a group with premature CHD the correlation was not significant anymore. There was a significant correlation between polymorphic loci of the promoter region of apo(a) gene and Lp(a) levels (+93C T, p=0.0166, STR, p<0.0001). Our study suggests that elevated Lp(a) level is an independent risk factor of CHD in carriers of other important CHD risk factors. Observed association of sequence variants of the promoter of apo(a) gene with Lp(a) levels is caused in part due to linkage to a restricted range of apo(a) gene length isoforms.
No takes yet. Share an insight, caveat, or question.
Zlatohlávek et al. (2008) conducted an observational in Atherosclerosis and coronary heart disease (CHD). Elevated Lipoprotein(a) [Lp(a)] levels and apo(a) gene promoter polymorphisms vs. Patients without coronary heart disease was evaluated on Association of Lp(a) levels with coronary heart disease (CHD) (p=0.0219). Lipoprotein(a) levels were elevated in patients with coronary heart disease carrying other important risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: